Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.65 USD | +3.67% |
|
-0.36% | -38.60% |
Jun. 12 | Cytek Biosciences to Seek M&A | CI |
Jun. 12 | Transcript : Cytek Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 09:20 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.60% | 715M | |
+6.15% | 213B | |
+9.25% | 184B | |
+27.85% | 153B | |
+33.63% | 113B | |
+0.80% | 63.66B | |
+18.66% | 53.53B | |
+0.13% | 49.11B | |
-4.55% | 38.73B | |
+2.06% | 36.26B |
- Stock Market
- Equities
- CTKB Stock
- News Cytek Biosciences, Inc.
- Morgan Stanley Trims Cytek Biosciences' Price Target to $14 From $15, Maintains Equalweight Rating